Selway Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-10,575
| Closed | -$1.64M | – | 82 |
|
|
2023
Q4 | $1.64M | Hold |
10,575
| – | – | 0.69% | 41 |
|
|
2023
Q3 | $1.58M | Sell |
10,575
-3,900
| -27% | -$573K | 0.73% | 41 |
|
|
2023
Q2 | $1.95M | Sell |
14,475
-2,745
| -16% | -$403K | 0.86% | 40 |
|
|
2023
Q1 | $2.74M | Sell |
17,220
-22,417
| -57% | -$3.43M | 1.32% | 33 |
|
|
2022
Q4 | $6.41M | Buy |
39,637
+500
| +1% | +$76.7K | 3.39% | 7 |
|
|
2022
Q3 | $5.25M | Sell |
39,137
-1,213
| -3% | -$174K | 3.07% | 8 |
|
|
2022
Q2 | $6.18M | Buy |
40,350
+100
| +0.2% | +$15.3K | 3.43% | 5 |
|
|
2022
Q1 | $6.53M | Buy |
40,250
+1,740
| +5% | +$253K | 3.16% | 7 |
|
|
2021
Q4 | $5.21M | Sell |
38,510
-250
| -0.6% | -$29.5K | 2.47% | 11 |
|
|
2021
Q3 | $4.18M | Buy |
38,760
+100
| +0.3% | +$11.4K | 2.28% | 14 |
|
|
2021
Q2 | $4.36M | Buy |
38,660
+350
| +0.9% | +$39.4K | 2.33% | 14 |
|
|
2021
Q1 | $4.15M | Buy |
38,310
+1,020
| +3% | +$109K | 2.41% | 13 |
|
|
2020
Q4 | $4M | Buy |
37,290
+4,050
| +12% | +$389K | 2.43% | 15 |
|
|
2020
Q3 | $2.91M | Sell |
33,240
-50
| -0.2% | -$4.71K | 2.06% | 18 |
|
|
2020
Q2 | $3.27M | Buy |
33,290
+175
| +0.5% | +$15.4K | 2.59% | 12 |
|
|
2020
Q1 | $2.52M | Sell |
33,115
-3,160
| -9% | -$269K | 2.43% | 15 |
|
|
2019
Q4 | $3.21M | Sell |
36,275
-620
| -2% | -$51.5K | 2.21% | 16 |
|
|
2019
Q3 | $2.79M | Buy |
36,895
+2,495
| +7% | +$171K | 2.05% | 19 |
|
|
2019
Q2 | $2.5M | Buy |
34,400
+18,150
| +112% | +$1.43M | 1.68% | 24 |
|
|
2019
Q1 | $1.31M | Buy |
16,250
+2,375
| +17% | +$194K | 0.88% | 40 |
|
|
2018
Q4 | $1.28M | Sell |
13,875
-300
| -2% | -$26.4K | 0.94% | 42 |
|
|
2018
Q3 | $1.34M | Sell |
14,175
-4,300
| -23% | -$408K | 0.81% | 46 |
|
|
2018
Q2 | $1.71M | Sell |
18,475
-1,600
| -8% | -$156K | 1.05% | 36 |
|
|
2018
Q1 | $1.9M | Sell |
20,075
-1,900
| -9% | -$209K | 1.18% | 32 |
|
|
2017
Q4 | $2.13M | Sell |
21,975
-5,300
| -19% | -$500K | 1.25% | 31 |
|
|
2017
Q3 | $2.42M | Sell |
27,275
-800
| -3% | -$60.9K | 1.4% | 28 |
|
|
2017
Q2 | $2.04M | Sell |
28,075
-13,600
| -33% | -$914K | 1.17% | 35 |
|
|
2017
Q1 | $2.72M | Sell |
41,675
-300
| -0.7% | -$18.9K | 1.52% | 23 |
|
|
2016
Q4 | $2.63M | Buy |
41,975
+475
| +1% | +$29K | 1.57% | 22 |
|
|
2016
Q3 | $2.62M | Sell |
41,500
-35,400
| -46% | -$2.29M | 1.63% | 23 |
|
|
2016
Q2 | $4.76M | Buy |
76,900
+10,200
| +15% | +$622K | 3.06% | 5 |
|
|
2016
Q1 | $3.81M | Sell |
66,700
-18,700
| -22% | -$1.04M | 2.63% | 11 |
|
|
2015
Q4 | $5.06M | Buy |
85,400
+18,200
| +27% | +$1.05M | 3.39% | 4 |
|
|
2015
Q3 | $3.66M | Buy |
67,200
+1,400
| +2% | +$91.1K | 2.31% | 13 |
|
|
2015
Q2 | $4.42M | Sell |
65,800
-19,600
| -23% | -$1.28M | 2.43% | 8 |
|
|
2015
Q1 | $5M | Buy |
+85,400
| New | +$5.16M | 2.64% | 7 |
|
Other funds holding ABBV
Selway Asset Management's ABBV Position: Q1 2024 in Review
Selway Asset Management sold out of AbbVie (ABBV) in Q1 2024, closing a stake of 10,575 shares — an estimated $1.64M sold.
Selway Asset Management first reported a position in ABBV in Q1 2015 and held it in 36 quarters. The position peaked at $6.53M in Q1 2022. 3,379 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.
- Selway Asset Management reported no remaining AbbVie position as of Q1 2024 after selling out during the quarter.
- Selway Asset Management sold 10,575 AbbVie shares in Q1 2024, an estimated $1.64M.
- Selway Asset Management first reported a position in AbbVie in Q1 2015 and held it in 36 quarters.
- Selway Asset Management's AbbVie position peaked at $6.53M in Q1 2022.
- 3,379 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.
Based on Selway Asset Management's 13F filing for Q1 2024, filed 10 Apr 2024.